News Sentiment

PCSA sentiment intelligence

Processa Pharmaceuticals Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 52 Balanced news tone 54 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 2.31 Week of 17 Jul 2026
Weighted tone 52/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

84/100 classification confidence.

Company focus 45

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+6.9% over one week, +9.0% over four weeks, trend inactive, and below fair value.

Latest direct headline Neutral

Processa Pharma (PCSA) Stock Analysis Report | Financials & Insights

Market Reaction

Price moving ahead of tone

62/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 84/100 classification
One-week reaction 6.9% Price confirming higher
Trend fit Trend inactive 9.0% over four weeks
Fair value -95.3% Below fair value
Value support

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 11
Neutral 40
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 45
Industry context 9
Sector context 0

Sources

Coverage mix

Publishers
Stock Titan 15
Market source 7
Investing.com 7
TradingView 6
Moomoo 5
TradingKey 5
Investing.com Canada 2
simplywall.st 2

Event Lens

What the news is about

Classified themes
Market update 35
Earnings 15
Deals and strategy 3
Macro sensitivity 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 31-54 of 54
TradingKey Direct company coverage

Processa Pharmaceuticals Inc (PCSA) Institutional Confidence

This article provides an "Institutional Confidence" score for Processa Pharmaceuticals Inc (PCSA), noting a score of 3.00 as of June 18, 2026. It details key institutional shareholders and their recent activity, including HX Entertainment Ltd with a significant ownership and incr

Tone
Neutral 50/100
Event
Market update
Published
17 Jun 2026 23:09
Source
TradingKey
Investing.com Direct company coverage

Processa Pharmaceuticals chief business officer Lin buys $4,064 stock

Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals, purchased 1,831 shares of the company's common stock for $4,064 at $2.22 per share. This transaction increases his direct holdings to 11,007 shares, with an additional 1,740 shares held indirectly. The pu

Tone
Positive 65/100
Event
Market update
Published
17 Jun 2026 22:40
Source
Investing.com
Stock Titan Direct company coverage

Processa Pharmaceuticals (PCSA) officer adds 1,831 shares in open-market buy

Patrick Lin, Chief Business - Strategy Officer at Processa Pharmaceuticals (PCSA), purchased 1,831 shares of Common Stock in an open-market transaction at $2.22 per share. Following this acquisition, Lin directly owns 11,007 shares and indirectly holds 1,740 shares through the Li

Tone
Positive 63/100
Event
Deals and strategy
Published
16 Jun 2026 20:40
Source
Stock Titan